Sakhanda Wire
NVDA $154.51 -1.04% MSFT $506.49 -2.22% GOOGL $281.27 -0.86% META $621.51 -0.78% AMZN $256.90 -0.33%
← Back to the news

Google DeepMind unveils AlphaGenome 2 for studying DNA and disease

Researchers at Google DeepMind have introduced AlphaGenome 2, an artificial intelligence model intended to help explain how changes in DNA influence different types of cells. The work addresses a difficult question in biology: how genetic changes can have different effects in heart muscle, skin and immune cells, even though nearly every cell in the human body contains the same DNA.

Cells behave differently because they activate and deactivate different genes. Those activity patterns can also change, and understanding their relationship with DNA variations may help scientists investigate the cellular origins of disease. Google DeepMind presents AlphaGenome 2 as a tool that can give researchers a more detailed view of these processes. The company says the model could provide important clues about why diseases develop and help indicate possible directions for new treatments.

AlphaGenome 2 follows AlphaGenome, DeepMind’s genome-predicting AI model released last year. The new system is part of Google DeepMind’s effort to use AI to study the connection between genetic information and cell behavior.

Written by Sakhanda Wire AI from reporting by The Verge. Facts, quotes and full context are in the original article below.

Originally published by The Verge on

Read the original on The Verge ↗

The reporting and the image belong to The Verge and are credited and linked above; the text on this page is Sakhanda Wire's own summary.

← Back to the news

More stories

All the latest news